Carter Bankshares, Inc.
NASDAQ:CAREBanks - Regional
-$0.20 today
- Market cap
- $635.59M
- Beta
- 0.55
- P/E (TTM)
- 6.2
- EPS (TTM)
- $4.95
- Dividend yield
- 0.33%
Volume 0.19M
Average 0.32M
CARE Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Carter Bankshares, Inc.NASDAQ: CARE
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 58.5% from a year ago
Cash & equivalents stood at $36.96M at the end of Q1 FY2026, down 58.5% from a year earlier and down 64.9% from the prior quarter. Over 3 fiscal years it compounded at +30.9% a year.
Context
- Cash & equivalents amounted to 0.8% of total assets at the end of Q1 FY2026, down 1.1 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -58.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 105.16M USD
- Year-over-year change
- -19.8%
- 4-year CAGR
- -21.6%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 105.16M | -19.8% |
| FY2024 | 2024-12-31 | 131.17M | +140.6% |
| FY2023 | 2023-12-31 | 54.53M | +16.3% |
| FY2022 | 2022-12-31 | 46.87M | -83.1% |
| FY2021 | 2021-12-31 | 277.8M | — |
Cash & Equivalents vs competitors
How CARE compares with its peers on the latest reported figures
- CARE's Mar 2026 cash & equivalents of $36.96M is the 8th highest of the 11 companies compared; the peer median is $79.82M.
- Its year-over-year change of -58.5% is the 7th highest of 11, against a peer median of -21.2%.
- Cash & equivalents amounts to 0.8% of total assets for CARE, versus a peer median of 2.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $600.3M | +586.4% | +98.8% | 16.5% | |
| Mar 2026 | $208.9M | -28.5% | -13.3% | 6.2% | |
| Mar 2026 | $146.61M | -14.0% | +14.5% | 6.1% | |
| Mar 2026 | $114.54M | +176.4% | +7.4% | 2.5% | |
| Mar 2026 | $82.22M | -6.7% | -4.3% | 1.8% | |
| Mar 2026 | $77.43M | +1.9% | +43.7% | 2.8% | |
| Mar 2026 | $38.78M | -86.0% | +38.5% | 1.0% | |
| Mar 2026 | $36.96M | -58.5% | +30.9% | 0.8% | |
| Mar 2026 | $12.63M | -98.1% | +35.8% | 0.1% | |
| Mar 2026 | $9.44M | -92.4% | +16.1% | 0.4% | |
| Mar 2026 | $7.98M | -93.5% | -6.0% | 0.4% | |
| Peer median (excluding CARE) | $79.82M | -21.2% | +15.3% | 2.1% | |
Competitors are the stored peer set for CARE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 277.8M | 46.87M | 54.53M | 131.17M | 105.16M |
| Short-term Investments | 922.4M | 836.27M | 719.64M | 654.95M | 383.51M |
| Net Receivables | 0 | 0 | 59.36M | 63.45M | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 1.2B | 883.14M | 833.53M | 849.57M | 488.67M |
| Property, Plant & Equipment (Net) | 75.3M | 72.11M | 73.71M | 74.33M | 72.5M |
| Goodwill | 0 | 0 | 0 | 0 | 1.19M |
| Intangible Assets | 0 | 0 | 0 | 0 | 940K |
| Long-term Investments | 2.72B | 3.06B | 3.41B | 3.56B | 4.13B |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 141.83M | 194.2M | 196.44M | 176.02M | 161.82M |
| Total Non-current Assets | 2.93B | 3.32B | 3.68B | 3.81B | 4.36B |
| Total Assets | 4.13B | 4.2B | 4.51B | 4.66B | 4.85B |
| Account Payables | 0 | 0 | 0 | 0 | 0 |
| Short-term Debt | 0 | 17.87M | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.7B | 3.63B | 3.72B | 4.15B | 4.21B |
| Total Current Liabilities | 3.7B | 3.65B | 3.72B | 4.15B | 4.21B |
| Long-term Debt | 7M | 180.55M | 393.4M | 70M | 178.5M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 20.67M | 44.93M | 45.98M | 51.46M | 42.84M |
| Total Non-current Liabilities | 27.67M | 225.48M | 439.38M | 121.46M | 221.34M |
| Total Liabilities | 3.73B | 3.88B | 4.16B | 4.27B | 4.43B |
| Common Stock | 26.43M | 23.96M | 22.96M | 23.07M | 22.08M |
| Retained Earnings | 235.48M | 285.59M | 309.08M | 333.61M | 364.97M |
| Accumulated OCI | 1.7M | (85.62M) | (71.44M) | (64.52M) | (42.16M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 407.6M | 328.63M | 351.24M | 384.31M | 419.7M |
| Total Debt | 7M | 198.42M | 393.4M | 70M | 178.5M |
| Net Debt | (270.8M) | 151.55M | 338.87M | (61.17M) | 73.34M |
Carter Bankshares, Inc.
NASDAQ:CARE
Intrinsic Alpha fair value
Locked
Current Price
$28.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.